These granules, available in 25 mg, 50 mg, and 75 mg per unit dose packets, are a generic equivalent of Kalydeco Oral ...

Johnson & Johnson has won Food and Drug Administration priority review for its application seeking approval of nipocalimab in certain patients with generalized myasthenia gravis.

With a decade-long collaboration history, the companies have previously demonstrated the value of their combined analysis ...

Gone are the days when Americans would criticize eggs for bad cholesterol. The FDA has put its stamp of approval for kids to ...

Onkos Surgical, a leading provider of innovative solutions for complex orthopaedic procedures, today announced that its ...

A Washington state-based nonprofit has launched a program training pharmacists to prescribe abortion medications via ...

Biotech stocks are poised for an exciting 2025 as experts watch for new weight-loss drugs, AI's impact and Trump's second ...

The condition, which is not contagious, usually appears in warm, wet parts of the body, such as armpits, under the breast, ...

Reforming patent litigation to mirror successful outcomes across Europe could significantly accelerate US biosimilar market ...